0001104659-26-056720
SEC filingQ1 revenue grew 16.6% to $215.4M driven by WAKIX demand, but profitability declined with operating income down 33.7% to $37.3M due to elevated operating expenses including higher legal fees and marketing activities.
Revenue for the three months ended March 31, 2026 reached $215.4 million, up 16.6% from $184.7 million in the prior year quarter. This growth stems from sustained demand for WAKIX, our lead product, which continues to drive top-line performance despite cost headwinds lower in the income statement.
Gross profit increased to $170.9 million from $152.7 million, delivering a 79.3% margin. The slower 11.9% year-over-year growth relative to revenue reflects higher cost of product sales, primarily driven by elevated royalties proportional to the net product revenue increase for WAKIX. Management notes this ties directly to the revenue expansion, with expectations for further cost of product sold increases as production ramps to meet future demand and diversify the supply chain.
Net income followed suit, dropping 28.7% to $32.5 million with diluted EPS at $0.55 versus $0.78 last year. The profitability challenges underscore the trade-offs of scaling operations and defending intellectual property in a competitive landscape.